EFS
NVO icon

Essex Financial Services’s Novo Nordisk NVO Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$556K Buy
8,052
+107
+1% +$7.39K 0.04% 386
2025
Q1
$552K Sell
7,945
-4,875
-38% -$339K 0.04% 358
2024
Q4
$1.1M Sell
12,820
-168
-1% -$14.5K 0.08% 219
2024
Q3
$1.51M Sell
12,988
-2,129
-14% -$248K 0.11% 175
2024
Q2
$1.94M Buy
15,117
+2,410
+19% +$309K 0.14% 139
2024
Q1
$1.63M Buy
12,707
+4,438
+54% +$570K 0.15% 138
2023
Q4
$856K Buy
8,269
+1,366
+20% +$141K 0.09% 218
2023
Q3
$628K Buy
6,903
+3,456
+100% +$314K 0.07% 246
2023
Q2
$558K Buy
3,447
+17
+0.5% +$2.75K 0.06% 261
2023
Q1
$546K Buy
3,430
+24
+0.7% +$3.82K 0.06% 271
2022
Q4
$460K Buy
3,406
+384
+13% +$51.9K 0.05% 291
2022
Q3
$301K Buy
3,022
+1,127
+59% +$112K 0.04% 339
2022
Q2
$211K Buy
1,895
+29
+2% +$3.23K 0.02% 450
2022
Q1
$207K Hold
1,866
0.02% 474
2021
Q4
$209K Buy
+1,866
New +$209K 0.02% 467
2019
Q1
Sell
-4,330
Closed -$246K 251
2018
Q4
$246K Buy
+4,330
New +$246K 0.08% 205
2017
Q3
Sell
-5,438
Closed -$233K 324
2017
Q2
$233K Buy
+5,438
New +$233K 0.05% 312
2017
Q1
Sell
-6,138
Closed -$220K 335
2016
Q4
$220K Sell
6,138
-1,567
-20% -$56.2K 0.05% 291
2016
Q3
$320K Buy
7,705
+75
+1% +$3.12K 0.08% 231
2016
Q2
$410K Sell
7,630
-2,750
-26% -$148K 0.1% 190
2016
Q1
$562K Sell
10,380
-1,175
-10% -$63.6K 0.14% 155
2015
Q4
$671K Sell
11,555
-725
-6% -$42.1K 0.16% 143
2015
Q3
$666K Buy
12,280
+180
+1% +$9.76K 0.17% 134
2015
Q2
$663K Hold
12,100
0.17% 140
2015
Q1
$646K Hold
12,100
0.17% 143
2014
Q4
$512K Hold
12,100
0.13% 172
2014
Q3
$576K Buy
12,100
+1,200
+11% +$57.1K 0.17% 143
2014
Q2
$503K Buy
10,900
+500
+5% +$23.1K 0.15% 156
2014
Q1
$475K Buy
10,400
+8,720
+519% +$398K 0.16% 149
2013
Q4
$310K Sell
1,680
-150
-8% -$27.7K 0.1% 198
2013
Q3
$310 Hold
1,830
0.1% 190
2013
Q2
$284K Buy
+1,830
New +$284K 0.1% 194